159 related articles for article (PubMed ID: 7462769)
1. Occurrence of enzyme-immunoglobulin complexes in chronic inflammatory bowel disease.
Leroux-Roels GG; Wieme RJ; de Broe ME
J Lab Clin Med; 1981 Mar; 97(3):316-21. PubMed ID: 7462769
[TBL] [Abstract][Full Text] [Related]
2. Evidence against the presence of circulating immune complexes in chronic inflammatory bowel disease.
Soltis RD; Hasz D; Morris MJ; Wilson ID
Gastroenterology; 1979 Jun; 76(6):1380-5. PubMed ID: 155547
[TBL] [Abstract][Full Text] [Related]
3. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
D'Alessandro M; Mariani P; Lomanto D; Bachetoni A; Speranza V
Clin Immunol; 2002 Apr; 103(1):63-8. PubMed ID: 11987986
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
[TBL] [Abstract][Full Text] [Related]
5. Measles IgM immunoreactivity in patients with inflammatory bowel disease.
Balzola FA; Khan K; Pera A; Bonino F; Pounder RE; Wakefield AJ
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):378-82. PubMed ID: 9789132
[TBL] [Abstract][Full Text] [Related]
6. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum anti-carbonic anhydrase II antibodies in patients with ulcerative colitis.
Andoh A; Fujiyama Y; Yoshioka U; Sasaki M; Araki Y; Tsujikawa T; Bamba T
Int J Mol Med; 2002 May; 9(5):499-502. PubMed ID: 11956656
[TBL] [Abstract][Full Text] [Related]
8. Studies on monocytes in inflammatory bowel disease: factors influencing monocyte lysosomal enzyme activity.
Mee AS; Nuttall L; Potter BJ; Jewell DP
Clin Exp Immunol; 1980 Mar; 39(3):785-91. PubMed ID: 7379337
[TBL] [Abstract][Full Text] [Related]
9. [Occurrence of lactate dehydrogenase linked immunoglobulin (LDH-Ig) and its clinical significance].
Yamamoto K; Hattori Y; Nakamura J; Ohba Y; Kawata R; Miyaji T
Rinsho Byori; 1986 Apr; 34(4):449-53. PubMed ID: 3747200
[No Abstract] [Full Text] [Related]
10. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
11. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
[TBL] [Abstract][Full Text] [Related]
12. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
Nos P; Argüello L; Hoyos M; Ramírez JJ; Hinojosa J; Molés JR; García A; Berenguer M; Berenguer J
Rev Esp Enferm Dig; 1996 Jul; 88(7):470-4. PubMed ID: 8924324
[TBL] [Abstract][Full Text] [Related]
13. Immune complexes in ulcerative colitis and Crohn's disease.
Hodgson HJ; Potter BJ; Jewell DP
Clin Exp Immunol; 1977 Aug; 29(2):187-96. PubMed ID: 908171
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease.
Gouni-Berthold I; Baumeister B; Berthold HK; Schmidt C
Hepatogastroenterology; 1999; 46(27):1720-3. PubMed ID: 10430330
[TBL] [Abstract][Full Text] [Related]
15. Circulating immune complexes in inflammatory bowel disease.
Jewell DP; MacLennan IC
Clin Exp Immunol; 1973 Jun; 14(2):219-26. PubMed ID: 4197968
[TBL] [Abstract][Full Text] [Related]
16. [Serum immunoglobulin levels in ulcerative colitis and Crohn's disease].
Veloso FT; Torrinha JF; Ribeiro AT
Acta Med Port; 1981; 3(1):37-42. PubMed ID: 7304267
[No Abstract] [Full Text] [Related]
17. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
[TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease.
Cabral VL; Miszputen SJ; Catapani WR
Hepatogastroenterology; 2003; 50(50):412-5. PubMed ID: 12749235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
